INFLAMMATORY RESPONSE RESEARCH
Inflammatory Response Research is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions. Their initial product is an oral combination of levocetirizine (Xyzal) and montelukast (Singulair) at specific dosing for the treatment of influenza. Parallel research is focused on an intravenous (IV) preparation for the treatment of traumatic brain injury and severe cases of influenza. IRR was founded in 2011 and is headquartered in Santa Barbara, California.
INFLAMMATORY RESPONSE RESEARCH
Industry:
Biotechnology Developer Platform Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Santa Barbara, California, United States
Country:
United States
Website Url:
http://www.irrinc.net
Total Employee:
1+
Status:
Active
Contact:
(805) 681-1522
Email Addresses:
[email protected]
Total Funding:
1.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Sitelinks Search Box IPv6 Yoast WordPress SEO Plugin Google Apps For Business
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.irrinc.net
- Host name: 74-208-236-70.elastic-ssl.ui-r.com
- IP address: 74.208.236.70
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
